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ABSTRACT
Rebecca A. Driver, for the Master’s in Science degree in Rehabilitation Counseling at
Southern Illinois University Carbondale.
TITLE: U.S. SOCIETY AND THE EVOLVING NEEDS OF THE BABY BOOMER
GENERATION AS IT RELATES TO ALZHEIMER’S DISEASE
MAJOR PROFESSOR: Dr. Thomas Upton
The Baby Boomer generation, those born between the years 1946-1964, are beginning
to reach the age of when symptoms of initial onset of Alzheimer’s Disease become
prevalent. This causes a concern for society in the United States due to the high
number of persons that make up this generation that are likely to significantly increase
the already high number of Alzheimer’s Disease cases in the United States. Causes for
concern include the high number of people within this generation reaching age of initial
onset of Alzheimer’s disease, the impact the disease as a whole on individuals, as well
as their families, caregivers, and society. While there is no cure for the progression of
Alzheimer’s disease currently, research into the development of a cure has been
deemed a priority. There are growing concerns of the level of care available to the
elderly population and the lack of diagnosis in the early stages of the disease. Research
presents resolutions for society, that when implemented, can alleviate some of these
concerns. Further research into the alleviation of the current and future concerns that
the Baby Boomer Generation generates for United States’ society is discussed.
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CHAPTER 1
INTRODUCTION
The study looks into contemporary U.S. society and assesses if the evolving
needs of persons and families for the aging population with Alzheimer's disease. The
purpose of this study is to look into the effects that the Baby Boomer generation will
have on United States society, current concerns and future concerns that AD imposes,
recent solutions, and possible solutions in the future.
Looking into the generational information, it is estimated that 79 million people
were born in the United States between the years 1946 and 1964 (Goldsmith, 2011).
This generation is known as the “Baby Boomers”, and is one of the largest generations
that have been seen thus far in the history of the United States (Goldsmith, 2011). The
people who are from the start of the Baby Boomer generation have just surpassed the
age of 65 (Goldsmith, 2011). According to a report by the Alzheimer's Association, an
estimate of 1 in 8 people of this generation develops Alzheimer's disease or dementia
after the age of 65 (Goldsmith, 2011). Looking at such a high number of people who
make up the Baby Boomer generation, and having 1 in 8 people developing this
condition, this adds up to around 10 million people of this generation developing
Alzheimer's or dementia (Goldsmith, 2011).
Currently, there are an estimated 5.3 million people with Alzheimer's disease in
the United States (Goldsmith, 2011). That number is expected to double, and by 2050
can be likely to hit 16 million people (Goldsmith, 2011). The impacts that Alzheimer's
currently has on this country is already high, but by 2050 with the number of Alzheimer's
cases on the rise, the impacts will be colossal (Goldsmith, 2011). Not only are the costs
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significant, but also the physical and emotional toll that the disease takes on the
individual as well as the family. It is of great importance to look into the effects that this
disease currently has, and will have, on society.
Background
Current concerns related to this study include that there is no cure for
Alzheimer's disease at this time (Goldsmith, 2011). Researchers, scientists, and the
government have deemed finding a cure for the degenerative brain disorder that
typically begins later in life of great importance in the United States (Wierenga & Bondi,
2011). Being that this disease slowly takes away memory and therefore the ability for a
person to care for themselves, it takes a large toll on the person themselves (Goldsmith,
2011). When a person is no longer able-bodied and cannot care for themselves, the
responsibility lies in the hands of family members, friends, or outside care givers
(Goldsmith, 2011). One of the major concerns currently is the financial impact that this
disease has not only for the individual, but also for the family and society (Goldsmith,
2011).
It is important for society and people within the healthcare fields to become
aware of the growing concerns due to the large number of people that make up the
Baby Boomer generation and the effects that Alzheimer's disease will have on not only
the generation itself, but also on society as a whole. Within the fields that students
study, each have a primary focus which can include working with people from birth to
old age. When students and/or workers have a primary focus on the younger
generations, they may not have the opportunity to learn about the concern of this age
group and the impacts that it will have on society entirely. Awareness is of upmost
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importance, as well as investigating and resolving the unresolved concerns of this
subject.
Significance of the Study
Being that awareness and resolving the current concerns that this disease will
have on society is of upmost importance, it is evident that there is a need to look into
these concerns in depth and consider what may be potential possibilities to resolving
these concerns. There are many concerns about the subject of Alzheimer's disease as
a whole, especially with the Baby Boom generation starting to make up the older
population in the United States. With the age of onset of Alzheimer's disease and those
of the Baby Boomer generation meeting these ages of onset, there is high concern of
how to care for a vast number of cases that is expected to rise significantly.
There are also concerns that there is still not a cure or a treatment that can
prevent the progression of Alzheimer's disease. There is a very significant need for
further research to find a treatment, and for the funding for this research to possibly one
day find a preventative drug to prevent Alzheimer's disease from taking the lives of
many people in the United States every year. The United States is currently faced with
an issue that will impact individuals with Alzheimer's disease, and also their families and
caregivers, and society as a whole. It is necessary for the effects of Alzheimer's disease
on society to be looked at closely, and to find measures that can help resolve these
effects and concerns that it poses. By putting forward research collected from the
literature, it can provoke others within the healthcare and rehabilitation field to expand
and hopefully gain resolution to one or more of the current concerns that are presented
to today's society.
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Purpose
The purpose of this research is to identify how significant of an impact that
Alzheimer’s Disease and the Baby Boomer generation will have on society as a whole,
and to see what has been done and has been proposed to be carried out in the future to
provide possible solutions to this impact. To approach this, I will look into the effects on
the individual with Alzheimer's disease, families and caregivers, and on society as a
whole. I will look into current research within the last five years to provide awareness on
solutions that have been brought forward as well as possible solutions that can help to
alleviate these future concerns. Research databases such as EBSCOhost and
AcademicSearch Premier will be utilized, and the review of literature from various peer
reviewed scholarly journals will be carried out to identify the information necessary for
this research matter.
Definition of Terms
Upon providing a review of literature that was researched for the means of
completing this paper, medical terms as well as the names of government programs are
discussed. Clarification of terminology may be of benefit to those reviewing this review
of literature.
Medicaid: a government program that pays for specific health services and nursing
home care for the elderly (Simmons, 2011). Medicaid is the primary public payer for
long-term care (Simmons, 2011).
Medicare: a federal health insurance program for those sixty-five or older, individuals
with end-stage renal disease, and some people with disabilities (Tierney, 2013). To be
eligible, age, special conditions, employment are all considered (Tierney, 2013).
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Medicare was passed as a part of the Social Security Act of 1965, and is intended to
give financial protection to older adults to protect them from the elevated cost of illness
and hospitalization (Tierney, 2013).
Degenerative Brain Disorder: A disorder caused by the decrease of nervous system
cells, or neurons (“Degenerative Brain Diseases,” 2014). The disorder is progressive,
and as the brain decays over time, an individual loses intellectual function including
speech, memory, and spatial skills (“Degenerative Brain Diseases,” 2014).

Formal Care: Care provided by staff including nurses and care workers, who are paid,
and work in care settings such as hospitals, care homes, or in patients’ homes (“Formal
Care of People with Dementia,” 2014).

Informal Care: Care provided by family members, friends, and/or neighbors, who are
unpaid, that give regular, continuous assistance to an individual (“Informal Carer,”
2013).

Long Term Care: A variety of services and support services that assist with activities of
daily living such as toileting, housework, money management, caring for pets, shopping
for everyday needs, and taking medication (“What is Long-Term Care,” 2014)
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CHAPTER 2
REVIEW OF THE LITERATURE

Overview of Organization of Chapter
Chapter two reviews Alzheimer’s disease and the impacts of the Baby Boomer
generation. The next section covers the current economic impacts of Alzheimer's
disease to the individual and families and caregivers of individuals with Alzheimer's
disease. Through this section, there is a focus on the impacts of formal care versus
informal care. The review of the literature will continue with focusing on the economic
impacts that Alzheimer's disease has on society as a whole due to the evolving needs
of the Baby Boomer generation. After reviewing the impacts that Alzheimer's disease
has not only on the individual of the Baby Boomer generation and their caregivers and
families, but also on society, the review will focus on current research on the disease as
well as on possible treatments that has been conducted as a result of these impacts.
Finally, current solutions striving towards alleviating these impacts and solutions that will
be carried out in the future will be looked at closely. The review of literature will
conclude with solutions being targeted to alleviate the concerns of the Baby Boomer
generation and the prevalence of Alzheimer's disease.
Etiology and Prevalence
Dementia is defined as a group of disorders that involve the pervasive,
progressive, and irreversible deterioration of cognitive functioning due to an array of
causes (Hamdy et al., 2013). In the United States, Alzheimer’s disease is the most
common form of dementia (Moschetti et al., 2012). AD affects an estimated 5.3 million
people in the United States (George, Whitehouse, & Ballenger, 2011), and makes up
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60-80 percent of all dementias (Carterville et al., 2012). Without effective treatments for
Alzheimer's disease and other dementias, an estimated 16 million Americans will be
affected by 2050 (Attea & Johns, 2010).
Alzheimer’s disease (AD) is an upcoming public health disaster (Cummings,
Ringman, & Metz, 2010), and is a major cause of disability and dependence for older
adults (Casey, 2012). Every 70 seconds someone in the United States progresses to
meeting the criteria for diagnosis of AD (Cummings, Ringman, & Metz, 2010).
Research shows that with the advancing age of the baby boom generation, that
by 2050, 14-16 million older Americans are estimated to have AD (Wierenga & Bondi,
2011) (Attea & Johns, 2010). In 2012, the first cohort of 76 million people who are of the
Baby Boomer generation who were born between 1946 and 1964 began to turn 65
(Yang et al., 2012). With the five million people in the United States who currently have
AD, and the aging “baby boomer” population is expected to add 10 million individuals to
this calculation (Cummings, Ringman, & Metz, 2010).
AD is an age-related degenerative brain disorder (Wierenga & Bondi, 2011). The
main clinical manifestation of AD is a progressive global dementia syndrome that
normally starts later in life (Wierenga & Bondi, 2011). Terms such as early-, mid-, and
late-stage AD are terms used to measure the progression of AD (Simmons, 2011). Early
stage AD is characterized by the individual no longer being able to function
independently (Simmons, 2011). In mid-stage AD, the individual will show major gaps in
memory as well as a compelling decline in cognitive function and personality changes
may begin to be seen as well (Simmons, 2011). In the late stages of AD, many
individuals no longer have the ability to verbally communicate, although some may be
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able to recall a few words (Simmons, 2011). There is also apparent severe physical
decline (Simmons, 2011).
Memory loss and cognitive decline, which are seen at the earliest point of AD,
may be misconstrued by caregivers as normal symptoms of the aging process (Leifer,
2009). In the later stages of AD, people have the inability to carry out everyday tasks
such as basic activities of daily living (Leifer, 2009). Activities of daily living include
eating and bathing by oneself (Leifer, 2009). Also, people diagnosed with AD may show
neuropsychotic symptoms including delusions, depression, and agitation at any point
during the progression of the disease (Leifer, 2009).
On a biological standpoint, AD is described as a clinicopathological state which
literally means the ‘loss of the ability to think’ (Shan, 2013). Patients show progressive
cognitive failure including the loss of the ability to form and retrieve new memories,
change in personality, and losing the ability to navigate in familiar environments (Shan,
2013). Common symptoms of AD are behavioral, and eventually individuals with AD
require 24 hour care and hands-on assistance with activities of daily living (7).
AD and many other dementias are progressive and over time, are fatal, and no one
currently survives these diseases (Attea & Johns, 2010).
From 2000-2006, the death rate of AD increased 46 percent, while other major
causes of death decreased (Attea & Johns, 2010). This figure is in part due to the
advancement of recognition and willingness by doctors and families to report that AD
was the cause of death (Attea & Johns, 2010). Also, as deaths from other diseases and
causes continue to decrease, more Americans are living longer to develop and die from
AD (Attea & Johns, 2010).
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The greatest risk factor for AD is age, and the likelihood of developing AD
increased from an estimated 1 percent in adults age 60 years to around 45 percent for
those ages 85 and older (Wierenga & Bondi, 2011). Being susceptible to AD has also
been found to be related to genetic risk factors (Wierenga & Bondi, 2011).Many times,
AD goes undiagnosed until it has progressed to the debilitating stages of the disease
which may play into the fact that less than half of people with the disease are diagnosed
currently with AD (Leifer, 2009).
Impacts to the Individual, Families and Caregivers
Research has found that for families who provide care for family members
diagnosed with Alzheimer’s disease will face out of pocket expenses that will increase
by 400 percent (Goldsmith, 2011). Providing care whether within an institution or at
home, using paid or unpaid services is costly for a person with Alzheimer’s disease (Fox
& Max, 2009).
Fidelity Investment estimated that for a 65 year old couple retiring in 2009, they
would require upwards of $500,000 to cover medical expenses for retirement if one
spouse was diagnosed with AD (“Planning Around Alzheimer’s,” 2009). This estimate is
more than double the cost it would take to cover medical expenses if neither one was
diagnosed with AD or another major disease (“Planning Around Alzheimer’s,” 2009).
Impacts of Formal Care
Direct costs that can include physician services, hospital care, nursing home
care, medication, adult daycare, homemaker services, respite care, transportation
services, and other services are all costs that an individual with Alzheimer’s disease and
caregivers are bound to face (Fox & Max, 2009). It is more likely for a person with
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Alzheimer’s disease who is a Medicare beneficiary to utilize inpatient hospital services
and see a physician than with those without the diagnosis (Fox & Max, 2009). A study
conducted in 2002 showed that the health care costs for individuals with and without AD
and other dementias are greater in patients with AD than in control individuals due to
the higher utilization of inpatient and skilled nursing facilities (Leifer, 2009).
In June 2009, Harvard University and the American Association of Homes for the
Aging (AAHA) conducted a study on sustainable housing for the aging (Simmons,
2011). The study found that the average monthly rate for assisted living facilities that
charge additional fees for Alzheimer’s disease and care for individuals with dementia is
$4,270 monthly or $51,240 per a year (Simmons, 2011).
Impacts of Informal Care
The burden has been shifted from the formal paid caregiving system to the
informal unpaid caregiving system (Fox & Max, 2009). This shift has allowed for federal
and state programs to save money, but without the assistance of caregivers, the
financial cost to public programs would significantly increase (Fox & Max, 2009).
The setting where those diagnosed with AD live is important in determining whether the
care they receive will be informal or formal, and who will take on the economic burden
of being a provider of that care (Fox & Max, 2009). Research had found that the cost of
providing care for those with AD in the community entails unpaid informal care which
accounts for three-quarters of the overall cost (Fox & Max, 2009). On the other hand,
twelve percent of the cost of care for people who are receiving care within an institution
is for unpaid informal care (Fox & Max, 2009).
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While it may seem that financially it is less costly to keep a person diagnosed
with AD residing in the home, it is clear that the economic burden of home care is
evident (Fox & Max, 2009). Research has found that most of the expenses for caring for
those with AD at home are taken care of by families (Fox & Max, 2009). Studies show
that the cost of informal care and value of caregiving that is unpaid is immense, and
ranges from two to three times the value of paid formal care (Fox & Max, 2009).
Delaying institutionalization may result in the saving of cost to public programs like
Medicaid that pays for care in skilled nursing facilities (Fox & Max, 2009). On the other
hand, it can shift the burden of care onto family caregivers for a longer period of time
(Fox & Max, 2009). In turn, the direct costs would be minimized, but the overall social
costs would be maximized (Fox & Max, 2009).
Many unpaid caregivers report positive effects of caregiving (Attea & Johns,
2010). However, many also experience significant levels of depression, and emotional
and serious negative effects on their health, employment, and financial security (Attea &
Johns, 2010). Family and friends who provide care for those living with Alzheimer’s
disease need support for the continuation of providing care to allow those with cognitive
impairments to reside in the home and avoid being institutionalized (Fox & Max, 2009).
The indirect costs of the disease also include the value of days that the individual with
the Alzheimer’s disease diagnoses lost, the value of informal caregiver services by
family members and friends that did not receive wages, and the costs of physical and
emotional suffering that those with the disease and their families experience. However,
those costs are many times rarely, if ever, calculated (Fox & Max, 2009).
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Economic Impacts of AD on Society
Studies have shown that Alzheimer’s disease poses an emotional and economic
burden on those with the diagnosis, their caregivers, professionals providing services,
and on society (Fox & Max, 2009) Society is faced with the economic cost of
Alzheimer’s disease in terms of all goods and services that are implemented for the
prevention, diagnosis, treatment, and care of people with Alzheimer’s disease (Fox &
Max, 2009). As of 2011, U.S. healthcare costs such as long-term care, health care, and
hospice services totaled $183 billion with Medicare and Medicaid covering an estimated
70% of these figures (Moschetti et al., 2012).
Society is directly impacted by the cost of research as it relates to the diagnosis,
treatment, causes, the course of Alzheimer’s disease, as well as the cost of educating
the public about the disease (Fox & Max, 2009). The National Institutes of Health
spends an estimated two-thirds of a billion dollars a year on Alzheimer’s related
research (Fox & Max, 2009). Studies have found that the cost to Medicare to provide
care to someone with Alzheimer’s disease will hike up more than 600 percent
(Goldsmith, 2011).
AD poses a burden that will continue in the future (Goldsmith, 2011). The U.S.
economy will face financial impacts that will excessive (Goldsmith, 2011). The annual
cost to society for Alzheimer’s disease has been estimated to surpass $1 trillion by 2051
(Goldsmith, 2011). The financial cost to society and individuals with AD is forecasted to
increase rapidly due to the aging population and those who are responsible for the
planning and financing of health care face the difficulty of using the increasingly scarce
resources against the current and future interventions aimed towards AD (Shearer et
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al., 2012). AD is likely to overcome the resources that society can use to assist in the
care of elderly individuals in the United States (Cummings, Ringman, & Metz, 2010).
Estimating the economic impact and cost to society for Alzheimer’s disease is
important for many reasons (Fox & Max, 2009). It is important to assess the magnitude
that the disease impacts society as it relates to other major diseases (Fox & Max,
2009). Also, it is important for the public to raise awareness of the impact that AD has
for the purpose of advocacy by placing an economic value on unpaid and paid care
(Fox & Max, 2009). Likewise, it is important for policy makers to be informed of the need
for health services in order to address AD. Finally, it is important to value the
contribution of the labor by informal caregivers (Fox & Max, 2009). The total cost of AD
on society is increasing due to the higher number of people living with the diagnosis of
AD with the aging population living longer (Fox & Max, 2009).
People with dementia make up one-quarter of older customers of paid homecare
services, and nearly one-half of customers of adult daycare, residential care, and skilled
nursing facility care (Fox & Max, 2009). Alzheimer’s disease also involves indirect costs
that use resources (Fox & Max, 2009). People with AD who have severe impairments
receive more formal and informal care than people with AD who have mild to moderate
impairment, regardless if they are residing in the community or in a nursing home (Fox
& Max, 2009). Based on current estimations of the prevalence rate of dementia and the
cost of the care of dementia found in cross sectional studies, the National Institutes of
Health (NIH) and the Alzheimer’s Association believe that the increased size of
population and extended longevity will advance to significant increases in dementia
cases among the Baby Boomer generation (Yang et al., 2012). Data shows that this
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could increase to as many as double the cases, and can surge the societal cost of
dementia care that could go to upwards of $20 million over the course of the next 40
years (Yang et al., 2012).
Research suggests that the cost of dementia care should be defined as a
longitudinal cost over the course of the disease (Yang et al., 2012). A person diagnosed
with AD for a shorter time before death at an older age may cost either more or less to
society than with a patient with a continued course of the disease that begins at a
younger age (Yang et al., 2012).
Current Research on AD
Current research has not found whether or not AD can be prevented (Shan,
2013). Technological progress is being done to find early detection that can give the
chance for those with a family history of AD to be attentive about symptoms and take
advantage of available assessments early on (Shan, 2013).
Research on Factors Associated with AD
However, research shows that there are factors that are associated with AD
(Shan, 2013). Smoking and consuming alcohol increases the risk of AD (Shan, 2013).
Studies show that being overweight or obese is associated as well (Shan, 2013). The
higher the body mass index, BMI, the higher the risk of AD (Shan, 2013). Psychosocial
factors have also been found to be associated with AD such as education and
socioeconomic status. The lower that socioeconomic status, research shows the higher
risk a person is to developing AD (Shan, 2013). Social network and social engagement
is associated with the likelihood of developing AD as well. Having poor networking and
engagement has been found to lead to reduced cognitive function and dementia (Shan,
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2013). Likewise, social isolation leads to a higher risk of developing the disease (Shan,
2013). Physical activity has been found to delay the onset of dementia and AD (Shan,
2013). Studies also have found that mental activity has a protective effect against the
development of dementia and AD (Shan, 2013).
Research has also found that dietary factors like the Mediterranean diet or the
consuming of antioxidants, polyunsaturated fatty acids, cereals, vegetables, and
omega-3 fatty acid minimize the incidence of dementia in population and observational
studies (Aprehamian & Forlenza, 2013). Likewise, participating in activities that engage
stimulation mentally, socially, and physically may delay the onset of dementia
(Aprehamian & Forlenza, 2013). Maximized frequency of cognitive engagement may
reduce the risk of dementia and also explain the relation between education and AD risk
(Aprehamian & Forlenza, 2013).
Current Concerns of the Level of Care for the Growing Older Population
As the population ages, the social, economic, and personal costs of dementia are
increasing (Casey, 2012). The quality of services being delivered in a long-term care
setting is of upmost importance in offering adequate living for individuals with AD
(Simmons, 2011). The long-term care system faces many difficulties (Simmons, 2011).
Population growth in people age 85 and older and other changes in society will
boost demand for long-term care by 2030 (Simmons, 2011). This demand will lead to
challenges in the current system that include low workforce retention, quality issues,
lack of technology, and a significant reliance on out-of-pocket and Medicaid funding
(Simmons, 2011). Current challenges will become more severe if they are not
addressed (Simmons, 2011), including that funding is significantly lower than funding for
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research for other diseases with alike or less effect in terms of prevalence, morbidity,
mortality, and costs (Attea & Johns, 2010).
The Alzheimer’s Association feels that much more is necessary to improve care
for individuals with AD (Attea & Johns, 2010). A problem of great significance is under
detection and diagnosis (Attea & Johns, 2010). Research has found that less than half
of all individuals with dementia in the United States have a diagnosis of AD in their
primary care medical record (Attea & Johns, 2010). Reasons for this may be due to the
challenge of detecting dementia in routine care visits, insufficient time with the physician
and reimbursement for diagnostic evaluations, some lack of knowledge of physicians on
how to carry out diagnostic evaluation for dementia, lack of approval for evaluation by
individuals, individual and family concerns regarding the stigma related to the diagnosis
of dementia, and physician doubt of the value of diagnosing an individual with AD if they
feel there is “nothing they can do” (Attea & Johns, 2010).
These factors are not the only issue (Attea & Johns, 2010). Numerous individuals
with AD and their families do not receive many kinds of care and services available to
them to assist them with their needs (Attea & Johns, 2010). These services include
ongoing medical management to assist in maintaining the individual’s physical health
and functioning, medical management, coordination of primary and specialty medical
care, information and education associated with community care; information,
consultation, and support for families to assist with caregiving needs, and information
and support during peak stress situations like hospitalizations and making decisions
regarding residential care, concerns of safety, and end-of-life concerns (Attea & Johns,
2010).
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There are many factors associated with why they are not receiving these care
and service options (Attea & Johns, 2010). There are an inadequate number of
geriatricians and other physicians who have been trained to detect and diagnose AD
and manage care for individuals with AD (Attea & Johns, 2010). Also, insufficient
physician time and reimbursement for care planning, care coordination, and family
consultation and support (Attea & Johns, 2010). Some physicians reported that they are
not knowledgeable enough about possible valuable community services and how to
assist families with caregiver tasks (Attea & Johns, 2010).
Policy makers, researchers, and scientists have made the quality of elderly care
of priority (Simmons, 2011). As the older population in the United States increases
significantly, more families are facing the challenge of providing quality care for the
elderly person in the home (Simmons, 2011). Even after realizing they need
professional help, families are often reluctant to send a member of the family to an
institution for long-term care due to feelings of guilt and concerns about the treatment of
their family member (Simmons, 2011).
Due to AD, individuals with this diagnosis need a substantial amount of care,
patience, and understanding (Simmons, 2011). The need for professionals in the
workforce who are well-trained is a major part of what is being addressed about
sustainable living (Simmons, 2011). Besides challenges with financing and service
delivery, providers and consumers experience difficulty bringing in and maintaining
paraprofessional workers to assist people who need long term care (Simmons, 2011).
There is a shortage of paraprofessional workers, who are certified nursing aides
in nursing homes and home care aides, and is currently a critical concern for providers
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of long-term care (Simmons, 2011). Currently, there is difficulty in finding staff, not only
as administrators, but also as direct and indirect caregivers that have the ability to
perform professionally within their specialties as well as developing positive
relationships with residents and other members of staff (Simmons, 2011).
With research that has been conducted up to this point, it has still remained a
significant challenge for clinicians and researchers to prevent AD (Aprehamian &
Forlenza, 2013). There has been recent emphasis on focusing on identifying possible
modifiable risk factors for dementia, including interventions designed to promote
cognitive engagement, physical activities, nutrition, as well as the increase in
antihypertensive medication use (Aprehamian & Forlenza, 2013).
Another concern with AD and the care of the aging population is that in 2005,
there was one geriatrician for every 5,000 Americans 65 and older. Only nine medical
schools in the United States have departments of geriatrics, out of 145 (Simmons,
2011). Very few schools have geriatric courses requirements (Simmons, 2011),
hospitals allow for internists to graduate with as little as six hours of geriatric training
(Simmons, 2011).
Current Research on Treatment of AD
The U.S. Food and Drug Administration (FDA) have given approval to five
medications to assist in the treatment of symptoms of AD, but there are no current
approved treatments that can prevent or cure AD (Attea & Johns, 2010). Studies have
found many benefits for early treatment and being persistent in implementing those
methods of treatment (Leifer, 2009). Research has found that detecting AD early may
assist in improving outcomes like cognition, function, and behavior (Leifer, 2009).
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Even though there is no current disease-modifying drug therapy approved for
AD, there is emphasis placed on identifying people in the pre-clinical stage so that as
strategies of treatment are developed, they can be used during the earliest period of AD
when they are most effective (Aprehamian & Forlenza, 2013). Recognizing and
diagnosing AD early provides individuals and families with an option to plan for the
future while the patient still has the opportunity to be a part of the process (Leifer, 2009).
Numerous drug therapies are being investigated for potential use for people with AD
and include donepezil, rivastigmine, galantamine, memantine, ginkgo biloba, and
vitamin B12/folate (Fox & Max, 2009).
Currently, ChEls are the approved therapy drug for mild-to-moderate AD (Leifer,
2009). Numerous studies have been carried out looking at the safety and efficiency of
donepizel, rivastigmine, and galantiamine (Leifer, 2009). Studies have concluded that
ChEls are an effective treatment for AD in the mild-to-moderate stages (Leifer, 2009).
ChEls assist with the cognitive, functional, and behavioral symptoms that appear during
the mild-to-moderate stages of AD (Leifer, 2009).
Likewise, another study was conducted with the study of rivastigmine over the
course of 26 weeks (Leifer, 2009). Over the duration of the study, patients who received
rivastigmine experienced a minor decline below baseline. However, patients who
received placebo showed a much more significant decline (Leifer, 2009). Individuals
with AD should be encouraged to be persistent with treatment if possible (Leifer, 2009).
A study was also done looking at the effectiveness of donepezil which showed
that a washout break from therapy for 6 weeks showed results of unrecoverable losses
in function (Leifer, 2009). With the current treatments that are available, long-term
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sustained improvements may be a vast expectation (Leifer, 2009). In pharmacotherapy
of AD, giving the opportunity to stabilize the symptoms and delaying further decline are
of primary importance of treatment (Leifer, 2009).
There are many pharmacologic treatments for AD; however individuals with AD
are many times not prescribed one of the cholinesterase inhibitors that have been
approved to treat mild-to-moderate AD or all stages of AD (Leifer, 2009). Likewise, the
Nmethyl D-aspartate receptor antagonist memantine, which has been approved for the
treatment of moderate-to-severe AD, is also many times not prescribed (Leifer, 2009). A
community-based study found that out of 2114 individuals with mild-to-moderate AD
who were a part of the study, only 35% were prescribed one of these approved
treatments (Leifer, 2009).
Drugs that have been developed that may treat AD have had limited success
when used in trials (Casey, 2012). By understanding these limitations, it allows nurses
to support patients with AD as well as the family with education about treatment options
(Casey, 2012). The reason for treatment is to delay AD from progressing and may not
result in improving the symptoms of AD (Leifer, 2009). For example, a 5 month study
was conducted that treated patients with AD with galantamine which as a result showed
very little improvement (Leifer, 2009). However, patients that were given the placebo
resulted in having a decline in Neuropsychiatric Inventory score (Leifer, 2009). What this
study shows is that for a healthcare practitioner who is treating an individual with AD, it
may seem as if the treatment is not effective, when the treatment results in preservation
of function over time (Leifer, 2009).
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Current Solutions by National Associations
The Alzheimer’s Association is the largest private funder of research, and has
been calling for the federal government to expand funding for Alzheimer’s disease
research (Goldsmith, 2011). The mission of the Alzheimer’s Association is to eliminate
AD and related dementias through research, maximization of care and support for those
affected, and minimizing the risk of dementia by promoting brain health (Attea & Johns,
2010). The Alzheimer’s Association is a voluntary health association with over 70
chapters in the world (Attea & Johns, 2010). The association provides funding to
research; provides information, support, and services to those with Ad and other
dementias as well as their caregivers; and carries out public information campaigns to
raise awareness of AD and related dementias (Attea & Johns, 2010).
The Alzheimer’s Association also advocates at the federal, state, and local levels
for funding research (Attea & Johns, 2010). Also, they advocate with the American
Geriatrics Society, for public policies to advance services and care for individuals with
AD (Attea & Johns, 2010). In 2011, the budget for research of Alzheimer’s disease was
$480 million (Goldsmith, 2011). The Alzheimer’s Association has stressed that partially
because of funded research by the government; the death rates for a number of major
diseases have decreased significantly (Goldsmith, 2011)
The Alzheimer’s Association has proposed that Medicare coverage and
reimbursement impose a package of primary care services. These services include
routine procedures for the detection of possible AD in primary care offices and clinics,
diagnostic evaluation, and initial care planning over a four month period following
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diagnosis and documenting the diagnosis and plan of care in the individual’s medical
record (Attea & Johns, 2010).
In the past few years and throughout the healthcare reform debate, advocacy for
care coordination has been targeted (Attea & Johns, 2010). Working closely with the
American Geriatrics Society, the Alzheimer’s association has advocated for government
policies and programs to boost coordination between primary and specialty medical
care. Likewise, they have also advocated increasing coordination between medical and
nonmedical settings and providers (Attea & Johns, 2010). These policies and programs
are important and beneficial for people with AD and related dementias due to cognitive
impairment and inability to coordinate their own care (Attea & Johns, 2010). The
Alzheimer’s Association encourages the U.S. Congress, state legislatures, and federal,
state, and local government agencies and policies to advance care and services for
those with AD and related dementias (Attea & Johns, 2010).
The Alzheimer’s Association offers a 24/7 helpline for those with AD and their
families and caregivers (Attea & Johns, 2010). The helpline is staffed with informational
specialists and master’s level counselors who give information, education, consultation,
support, and community referrals to those with AD and their families and caregivers
(Attea & Johns, 2010). The local chapter follows up with these individuals on the
following business day to give continued information, support, and referrals for services
that are necessary (Attea & Johns, 2010). The Alzheimer’s Association also gives public
information programs and numerous training programs for care providers (Attea &
Johns, 2010).
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Current Solutions by the Government
In January of 2011, President Obama deemed AD a national priority by signing
into law the National Alzheimer’s Project Act (NAPA) (1). The act will create a
coordinated national plan to assist in the overcoming of the AD crisis and will target the
coordination and evaluation of national efforts of AD research, clinical and institutional
care, home and community based programs and the outcomes (1).
The healthcare reform law that has recently been enacted includes care
coordination provisions that will be beneficial for those with AD, and includes transitional
care and medical home programs, care coordination pilot projects, and policies to
reduce hospitalizations that are unnecessary (Attea & Johns, 2010). Other provisions
from the healthcare reform that will boost care for those with AD include increased
federal funding for geriatrics training, a national long-term care insurance program, and
increased federal payments for Medicaid home and community services (Attea & Johns,
2010).
President Obama’s administration recently announced the plan to boost federal
funding for AD research and disease management which highlights the importance of
this health concern to the public (Moschetti et al., 2012). This announcement indicates
the immense need for more cost-effective, evidence- based clinical, community, and
public health interventions (Moschetti et al., 2012). The research is intensely focused on
the treatment, detection, and prevention of AD (Shearer et al., 2012). Currently, the
federal government contributes over $25,000 to assist in the care of those with the
Alzheimer’s disease for every $100 they put towards Alzheimer’s research (Goldsmith,
2011).
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Future Solutions for Individuals with AD, Their Families and Caregivers, and
Society
According to Goldsmith 2011, society must become more educated about AD.
The public can put in place strategies that research has shown to delay AD symptoms,
increase brain health, and cognitive function (1). The National Institute on Aging
recommends that mental stimulation, social engagement, physical exercise, and a
healthy diet that includes antioxidants (1). The Division of Aging implements these
components into their programs and services (1).
For those who strive to maintain brain health for as long as possible, research
shows that staying active and mentally curious is beneficial (Leifer, 2009). The
Alzheimer’s Association came out with the “maintain your brain” initiative which
suggests that reading, writing, working crossword puzzles, playing board games,
gardening, staying physically and socially active, and maintaining a brain-healthy low
fat, low cholesterol, and high levels of dark colored fruits and vegetables may all be
ways to do so (Leifer, 2009).
Carrying out these activities will need to be suited to an individual considering
their level of cognition. This will also change as AD progresses in the individual (Leifer,
2009). Other factors that are beneficial to individuals with AD as the disease progresses
are providing a safe environment for the individual and minimizing stimulation in excess
(Leifer, 2009).
For each symptom that may become expressed during the progression of the
disease, many tips are available for caregivers (Leifer, 2009). With indecisiveness, the
caregivers are encouraged to reduce choices (Leifer, 2009). If an individual with AD is
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showing disorientation, the caregiver is encouraged to provide cues, avoid relocation,
and possibly bring items that are familiar to the individual (Leifer, 2009). If
hallucinations are present, the caregiver should not be overly concerned as long as they
are not distressing to the individual, but if treatment is necessary, antipsychotic agents
can be considered (Leifer, 2009). However, the family and caregivers of the individual
must be fully informed of the risks as well as the benefits of these medications (Leifer,
2009). If the caregivers notice wandering, which typically occurs in moderate-to-severe
AD, later in the progression of the disease, it is suggested that the family or caregivers
register them in the Medic Alert and Safe Return Program, make the environment
secure with complex handles, and to inform neighbors (Leifer, 2009).
Future Solutions for Medical Treatment
There is urgency for the development of new drugs with disease-modifying
properties for AD (Aprehamian & Forlenza, 2013). A disease modifying drug is defined
as a pharmaceutical agent that is intended to slow the progression of the
neurodegenerative process by inhibiting crucial events in the pathophysiology of AD,
which constricts that pathological load (Aprehamian & Forlenza, 2013).
AD presents a particular problem to an ageing society due to the cost of care and the
progression towards effective treatments that can prevent the advancement or reversal
of AD to provide a noteworthy quality of life for as long as possible (Casey, 2012).
Investigating the best care options will continue to be of importance until sufficient
progress can be made on the nature of AD, its pathogenesis and treatments, or a cure
(Casey, 2012).
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When treatment can be given and is successful, it can reverse or even slow the
decline of cognition associated with AD (Fox & Max, 2009). This in turn can delay the
need for institutionalization and significantly minimize the need for informal care due to
the improvement of functioning for a person with AD (Fox & Max, 2009). There is a push
to attempt to convince policy makers that putting a drug on the Medicaid formulary will
results in long-term-care savings for the population of people with the diagnosis of AD
(Fox & Max, 2009). This could result in reducing the costs to programs such as
Medicare and Medicaid (Fox & Max, 2009).
Future Solutions Regarding Early Detection of AD
Early detection may assist in reducing costs related to AD treatment (Leifer, 2009).
Nursing home care is the most expensive component of caring for an individual with AD
(Leifer, 2009). In turn, delaying placement into a nursing home can help to lower the
cost of managing AD (Leifer, 2009). A study was conducted to assess the relationship
between treatment with donepezil and time of placement in a nursing home (Leifer,
2009). The study showed that an individual being placed in a nursing home was
delayed significantly for individuals using at least 5 mg/day of donepezil, and a
cumulative dose-response relationship in delaying nursing home placement was
observed in the persistent use of donepezil (Leifer, 2009). For individuals using 5
mg/day or more of donepezil for a duration of 9-12 months, the delay of the initial
placement of nursing home care for dementia was 21.4 months, and permanent
placement into a nursing home was delayed for 17.5 months compared with individuals
given less than 5 mg or less for a duration of 6 weeks (Leifer, 2009).
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Future Solutions by National Associations
Currently, Medicare covers and pays for specialty physician care such as
diagnostic evaluations, and for some imaging tests (Attea & Johns, 2010). As an
improvement, the Alzheimer’s Association is pursuing Congressional support and
passage of the Alzheimer’s Breakthrough Act. The Alzheimer’s Breakthrough Act asks
for a $2 billion investment annually in Alzheimer’s research that would strengthen AD
research as a priority of the National Institute on Aging (Attea & Johns, 2010). The act
would also give $15 million for comprehensive awareness and education campaign
efforts on AD and related dementias for health professionals and the public which would
be led by the Centers for Disease Control and Prevention (Attea & Johns, 2010).
Future Solutions Regarding Early Detection of AD
Early detection may assist in reducing costs related to AD treatment (Leifer, 2009).
Nursing home care is the most expensive component of caring for an individual with AD
(Leifer, 2009). In turn, delaying placement into a nursing home can help to lower the
cost of managing AD (Leifer, 2009). A study was conducted to assess the relationship
between treatment with donepezil and time of placement in a nursing home (Leifer,
2009). The study showed that an individual being placed in a nursing home was
delayed significantly for individuals using at least 5 mg/day of donepezil, and a
cumulative dose-response relationship in delaying nursing home placement was
observed in the persistent use of donepezil (Leifer, 2009). For individuals using 5
mg/day or more of donepezil for a duration of 9-12 months, the delay of the initial
placement of nursing home care for dementia was 21.4 months, and permanent
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placement into a nursing home was delayed for 17.5 months compared with individuals
given less than 5 mg or less for a duration of 6 weeks (Leifer, 2009).
Future Solutions for Physicians and Primary Care Providers
Due to the burden of AD falling on families of individuals with AD, primary care
providers are encouraged to monitor signs of caregiver stress and provide support
(Leifer, 2009). Numerous strategies are available to be shared with caregivers, and
include referrals to support groups and a local Alzheimer’s Association chapter (Leifer,
2009).
Primarily, individuals with the early stages of AD will first seek care in the primary
care setting (Leifer, 2009). Primary care providers should be open to the signs and
symptoms of AD since they are typically the first healthcare professionals that people
with AD see (Leifer, 2009). There are many tools that assist clinicians in recognizing
symptoms of AD and many treatments that may delay progression of those symptoms
(Leifer, 2009).
Early diagnosis of AD has several benefits (Leifer, 2009). Without a diagnosis,
the behavior an individual with AD expresses may be a challenge for family members to
understand (Leifer, 2009). Family members might put blame on the individual for
behaving in a way that is beyond their control, and may have denial that there is indeed
a medical problem (Leifer, 2009). An early diagnosis may allow for an increase of safety
if members of the family are aware that activities like driving or cooking may be high risk
for the individual with AD (Leifer, 2009). An individual with AD may have the opportunity
to participate in financial and legal planning, advance directives, and to discuss long-
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term care options (Leifer, 2009). When a diagnosis has been made, the individual, their
family or caregiver has the opportunity to start treatment (Leifer, 2009).
Having a clearer understanding of treatments that are available and awareness
that persistent and continuous treatment gives to individuals with AD through the
moderate-to-severe stages of the disease, is necessary to ensure that these individuals
are given optimal treatment and care throughout the duration of the disease (Leifer,
2009). The expectations for treatment provided by clinicians should be realistic, and the
expectations of the individual and their caregiver should be managed carefully to suit
their needs (Leifer, 2009).
The physician and other care professionals would provide the care planning
(Attea & Johns, 2010). It would be carried out in collaboration with the patient, when
possible, but would also utilize telephone counseling and in-person consultations with
the family or caregivers of which Medicare does not currently cover if the individual is
not present (Attea & Johns, 2010).
Future Solutions by Future Research
AD research must increase adequately with the magnitude of the threat it poses
to the US (Cummings, Ringman, & Metz, 2010). Research into how AD produces the
effects in the brain and how to best address these effects in human therapeutics must
be increased (Cummings, Ringman, & Metz, 2010). The UCLA-Easton Alzheimer’s
Center plans to increase resources, collaborations, and productivity to discover and
meet the scientific and social challenges that AD poses (Cummings, Ringman, & Metz,
2010).
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Future Solutions of Services and Support
There is a need for immediacy for services and programs to provide assistance
and support to informal caregivers (Fox & Max, 2009). By engaging people to
understand and think about AD and conditions that are related to it, there can be further
understanding of the disease, which can bring social change (Fox & Max, 2009). By the
public taking into account that the “phenomena of altered states of consciousness can
teach lessons about living and giving that are as valuable and important as our
everyday or “normal” way of being, then we may then begin to perceive different options
for addressing the needs of people with AD and those who care for them that transcend
the approaches that have shaped the Alzheimer’s policy discourse in America” (Fox &
Max, 2009).
An approach to AD that takes into account not only the discovery for medications
but also possible long-term-care strategies is extremely important, according to Fox &
Max, 2009. This is due to the fact that people are being given an AD diagnosis earlier in
the beginning stages of AD than previously before (Fox & Max, 2009). According to Fox
& Max 2009, if the general public begins to think in these terms, then it is possible to
shed light on how to provide the best care for those with AD and other disabilities that is
cognizant of the social and medical needs of a person (Fox & Max, 2009). Likewise,
there are rehabilitative measures that can be taken to assist with the needs of
individuals with AD (Leifer, 2009). These measures include developing and
implementing a daily routine that is predictable, simplifying tasks, and giving the
opportunity for independence (Leifer, 2009).
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The expectations of the individual with AD and their caregivers are encouraged
to be managed carefully and discussed, and being referred to an AD support group is
beneficial at this point in time (Leifer, 2009). It is also necessary for the long-term care
system to explore innovations to better the mix of financing and to improve delivery to
enhance the services that are being provided to long-term care consumers and their
families (Simmons, 2011).
With the aging of the baby boomer generation, housing developers are going to
be attentive to the physical design of homes, and may be more pressured to build
homes in which people can age in place (Simmons, 2011). The overall trend is steering
away from institutional and medical-based models (Simmons, 2011). The trend is
towards a social, community based, residential, or home-like models (Simmons, 2011).
Consumers are increasing a demand for more opportunities in options of care
(Simmons, 2011).
It is vital that owners and administrators understand what their management and
staffs responsibilities are and how to identify if they are being implemented accurately
(Simmons, 2011). They should give clear job descriptions and job responsibilities, have
a system for the observation and matching performance with what is expected, hold
staff accountable for performance, give regular feedback, and use those results to
identify and correct practice and performance concerns (Simmons, 2011). The delivery
in care being carried out properly would allow for staff and practitioners to predict
concerns more accurately and to explain to an individual and their family information
about the care being received (Simmons, 2011).
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Many long-term quality initiatives are attempting to better the quality of care and
life for elderly individuals in the care of long-term facilities (Simmons, 2011). One
initiative is to encourage the transformation and medical institutional settings to homelike settings that place emphasis on privacy, choice, and a feeling of well-being
(Simmons, 2011).
Likewise, Quality First, is another initiative that is the first national initiative that
asks providers to achieve excellence in the quality of care and services for elderly
individuals (Simmons, 2011). Another initiative is Advancing Excellence in America’s
Nursing Homes, which brings together providers, government agencies, and consumers
to encourage quality by setting goals that are measureable for providers (Simmons,
2011).
The long-term care system needs to ensure a vigorous supply of professional
and paraprofessional workers and address challenges recruiting, training, and retaining
these workers (Simmons, 2011). If there is no change, these challenges will worsen and
have a negative effect on consumers (Simmons, 2011). The long-term care system has
many goals including ensuring safety, preventing injuries, and enhancing the quality of
care and the quality of life of individuals in their care (Simmons, 2011). The government,
providers, consumers, and long-term care healthcare professionals need to address
quality issues that are in the system currently (Simmons, 2011). Implementing
advanced technology will enhance the quality of care and independence of their
patients as well as care management and care coordination (Simmons, 2011).
Long-term care mainly targets maintaining or improving the ability of the elderly
with disabilities like AD, to function as independently as possible (Simmons, 2011).
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Social and environmental needs are also part of long-term care (Simmons, 2011). Longterm care is available in a range of settings and what the individual and their caregivers
choose is dependent on the individual’s needs and preferences, availability of informal
support, and the reimbursement source (Simmons, 2011).
Providing competent and motivated employees ongoing training in interactive
relations with their patients, training in ethics, and training in delivering care in a positive
environment is crucial with successful management of communities for people with AD
(Simmons, 2011). Employees in the long-term setting need the authority and
responsibilities to make decisions about the care residents receive (Simmons, 2011).
In long-term care, an individual should have the ability to continue to live life on
their terms and to be provided with an appropriate level of care including with
unanticipated needs of the individual (Simmons, 2011). It is important that caregivers
maintain a professional attitude and have knowledge of how each individual’s cultural
background continues to influence their present attitudes and behaviors (Simmons,
2011). Personalized assessment tools assist the caregivers in knowing an individual’s
personality and preferences as well as their changing needs (Simmons, 2011).
Future Solutions by the Government
Since the Patient Protection and Affordable Care act was passed, the U.S. health
care system has been going through many changes (Yang et al., 2012). There have
been some policy interventions that target lifestyle change and are under consideration
(Yang et al., 2012). For example, the YMCA version of the Diabetes Prevention
Program nationally might minimize Medicare spending by an estimated $50 billion
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across the whole Baby Boomer cohort by preventing chronic diseases that are
associated to obesity (Yang et al., 2012).
Proposals of financial reform of Medicare and Medicaid and new service models
are being considered as well (Yang et al., 2012). Suggestions such as changing
Medicare hospice care guidance to be based on the care of the patients’ need instead
of estimated life expectancy and the proposition of Program for All-inclusive Care for the
Elderly model to encourage comprehensive care for elderly who become frail (12).
Further studies in regards to the cost effectiveness of these policy recommendations will
allow for valuable insights (Yang et al., 2012).
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CHAPTER 3
DISCUSSION

The impacts of AD due to the aging baby boomer population have raised
concerns for the future. Currently, AD affects around 5.3 million people in the United
States, and by 2050 is projected to directly impact another 10 million individuals of the
baby boomer generation.
Being that AD is an age-related degenerative brain disorder, it is characterized
by progressively manifesting a decline in cognitive and physical function, personality,
memory, and neuropsychotic symptoms over the course of time for an individual with
the disease. Due to the effects that AD projects onto an individual, it is necessary for
those who enter the later stages of AD receive 24 hour care and direct assistance with
activities of daily living.
The greatest factor playing into AD is age, and the chances of developing AD
symptoms are approximately 1 percent in adults age 60 to 45 percent of those age 85
and older. This is important to note with the baby boomer generation starting to hit 65
years of age, when onset of AD is becoming prevalent.
There are many concerns that not only individuals with AD face, but also their
families/caregivers, medical doctors, primary care providers, and society as a whole.
Individuals and their families and caregivers face high cost of care and significant
impacts to their own well-being, whether if formal care or informal care is chosen as a
method of care services. The cost and value of unpaid service that families and
caregivers provide is rarely calculated and taken into account the amount of the costs.
AD many times goes without being diagnosed until the later and debilitating stages.
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As mentioned above, not only do individuals with AD and their families and
caregivers face significant impacts due to AD, but so does society. Society faces an
economic burden with the costs of the research, goods, and services for preventing,
diagnosing, treatment, and care of those with AD. The economic impacts are not
coming to a halt in the near future. It has been estimated that the financial cost to
individuals as well as society is bound to increase dramatically due to the aging
population.
It is of great importance to understand the economic impact and cost to society
that AD will have because of the impacts to society, public awareness, advocacy,
awareness of policy makers, and to be aware of the contribution that informal caregivers
provide to those with AD.
So far, researchers have not been able to establish whether or not AD is
preventable. However, research has found there are factors that increase the likelihood
of an individual developing AD including lifestyle, socioeconomic and education status,
and dietary factors.
Currently, there are many concerns in regards to the level of care that is being
provided for the older population. These concerns are only projected to get more severe
if these issues are not addressed and solutions are not made. Due to the aging
population increasing rapidly, there will be a significant increase in demand for longterm care by 2030. There are current issues standing such as low workforce retention,
issues of quality, lack of technology, and a reliance on out-of-pocket and Medicaid
funding.
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Another concern is the under detection and diagnosis of AD which is prevalent in
the United States. Research has found that this may be due to a variety of reasons
including the current difficulty of detecting dementia during routine visits. Along with the
concern of under detection and diagnosis, many individuals and families are not being
provided with the many services and opportunities for care that are available. The
reasons for this significant problem are due to the lack of knowledge of some physicians
on possible community services of value and how to assist families with caregiver tasks.
When it does come to long-term-care, there is an excessive need for professionals and
paraprofessionals to care for this population and to have appropriate training to do so.
While there have been five medications approved to assist in treating AD, there
is still no cure or preventative drug therapy. However, research has found that there are
significant benefits of early detection of AD. Even with this breakthrough in research, it
is still imperative that a preventative drug therapy be developed to stop the progression
of AD.
There are many things being done currently to address these concerns and push
towards finding solutions. The Alzheimer’s Association plays a major part in finding
answers too many of the concerns earlier stated. The association pushes for funding
from the federal government, conducts research, maximizes opportunities for care and
support, and educates the public on awareness. The Alzheimer’s Association has also
made proposals to better current federal programs such as Medicaid.
The government is also addressing these concerns and taking a stand in finding
ways to alleviate these concerns. In the past few years, laws have been signed to assist
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in finding answers to the prevention of AD by funding research and addressing the need
for care.
While there has been some progress in striving to find answers to the concerns
that AD poses with the baby boomer generation, there are many things that society as a
whole is pushed to become aware of and implement. When it comes to individuals with
AD and their families and caregivers, there are many things that they can do in the
future. There are many recommendations of lifestyle habits and activities that
individuals can carry out to assist in the delay of onset of AD. For families and
caregivers that are assisting an individual who has already displayed symptoms of AD,
there are many strategies that are suggested to assist with the care and in turn can
assist with caregiver stress.
It is imperative for a drug with disease-modifying properties of AD to be
developed in the future. If such a drug is developed, it can reverse or slow the
progression of cognitive decline which would delay the need for an individual to be
institutionalized and for informal caregiving to require.
Further research needs to be conducted on the current treatments and
appropriate dosages that would delay the need for long term care and informal
caregiving. The Alzheimer’s Association is pushing for funding further future research
on these issues and others.
There is a push in the future for early detection of AD, which may reduce the
costs that are associated with treating AD. Along with early detection of AD, primary
care providers are being encouraged to look for signs of caregiver stress and provide
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support. Numerous strategies are available for caregivers, and referrals may be made
to support groups to assist their needs.
There is a significant need for an understanding of available treatment, and the
effects that persistent treatment has on an individual with the disease. Primary care
providers need to lay out realistic treatment expectations, and in a fashion that suits the
needs of each individual case. In the future, doctors are being pushed to be a part of
care planning to assist the needs of their patients.
In the future, it will be imperative that services and programs are available for
supporting informal caregivers. There needs to be further understanding of AD, which
can in turn bring social change. It is important for professionals and paraprofessionals
within the long-term care setting to address the issues with training and the retention of
workers.
Within the long-term care setting, and with the growing need for services for the
baby boomer generation, it will be important for the settings to be based on a social,
community based, and residential, home-like model. With the increase of demand for
opportunities in care options, it will be imperative that these options be available as
needed.
To further address the concern of the level of care being provided in long-term
care facilities, there are needs that need to be met by owners and administrators. By
giving clear job descriptions, job responsibilities, a system for observation and
performance, holding staff accountable as well as giving feedback, there would be an
opportunity for the advancement of current care.
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Implications for Professionals
It is evident that there are evolving needs for the baby boomer generation as it
relates to AD. With such high numbers of individuals rapidly becoming a part of the
older population, it is imperative that the concerns that society faces be addressed. With
the 10 million people that make up the baby boomer generation that are estimated to
develop AD, there are many things that society need to do to prepare for the evolving
needs that this imposes. There are many concerns, primarily relating to a lack of a
disease-modifying drug and preventative medicine, the level of care older people are
receiving, lack of awareness, lack of knowledge and training, and a lack of enough
funding to generate the research needed to potentially come closer to finding an
effective drug therapy.
It is important for professionals to be aware of the evolving needs for the baby
boomer generation. The toll of such a high number of people requiring long term care
and support services is dramatic. If enough funding can be implemented for future
research to discover if there is an option for prevention, it can help lead to the discovery
of a disease-modifying drug that will alleviate many of the other concerns that society
faces.
The level of care within long term care facilities needs to be evaluated. The
research shows that there are many ways to bettering these facilities and in turn will
help alleviate individual as well as family and caregiver stress. If staff is properly trained
and properly being oversaw by management and owners, then better care will be
possible, which in turn may give families and caregivers more of a sense of peace with
allowing their loved one to enter into long term care instead of being provided primarily
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informal care. This would allow for less stress upon the families and caregivers and
alleviate many of the concerns that they are currently facing. Another important
implication that research shows is the importance of allowing individuals to have as
much of a feeling of independence as long as possible. If this is implemented in the long
term care setting, then this may also give caregivers and families a sense of peace.
Training and knowledge of AD, services and support available, and care
management are all important when working with an individual with AD. Primary care
providers need to be aware of not only the current treatments that can assist with
symptoms of AD, but also resources where the individual and family and caregivers can
receive support through the progression of the disease.
Conclusions/Implications/Recommendations
Research has found that there are many concerns that are facing U.S. society
with the evolving needs for the baby boomer generation as it relates to AD. One of the
important concerns that have been noted in the review of literature is a need for
awareness and public education of AD and related dementias. There is also need for
the public awareness of the concerns that AD poses. If people within the rehabilitation
field as well as other healthcare fields become aware of this rising concern, it may bring
about more of a desire for people to become more actively involved in assisting this
population.
Also, if physicians and primary care providers become more aware of support
services for individuals and their families and caregivers, they will be able to refer them
to those who are rehabilitation counselors that will be able to provide support for
individual stress as well as family/caregiver stress. People in turn will be able to learn
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more about further services that can further assist them in the process of helping their
loved ones. People who work in the field of rehabilitation will be able to do their part in
assisting those affected by AD, and help to answer many concerns that society faces
currently, as well as in the future.
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